CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
From Hematologic Oncology Update by Dr. Neil Love
April 10, 2026 · 25 min · Season 25 · Episode 74
About this episode
Dr. Paul G Richardson discusses the function and future role of CELMoDs in treating multiple myeloma.
Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma. CME information and select publications here .
People in this episode
Host: Dr. Neil Love
Guest: Dr Paul G Richardson
Topics covered
- CELMoDs
- Multiple Myeloma
- Cancer Treatment
- Hematologic Oncology
- Medical Research
Keywords
- CELMoDs
- Multiple Myeloma
- Cancer Treatment
- Hematologic Oncology
- CME
Mentioned in this episode
Organizations: Dana-Farber Cancer Institute
Places: Boston, Massachusetts
More episodes of Hematologic Oncology Update
- Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances · May 23, 2026 · 59 min
- Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances · April 20, 2026 · 59 min
- Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review · April 1, 2026 · 25 min
- CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson · March 23, 2026 · 24 min
- Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review · March 21, 2026 · 29 min
- CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah · March 13, 2026 · 1h 3m
Explore listener stats, chart rankings, contacts and more on the Hematologic Oncology Update podcast page.